Ophthalmic Surgical Devices and Therapeutics Market - Snapshot

The global ophthalmic surgical devices and therapeutics market is expected to reach a value of US$ 68898.4 Mn by the end of 2026, expanding at a significant CAGR of 5.8% during the forecast period. Increase in prevalence and incidence rates of eye-related disorders, high unmet needs in patients with ocular diseases, increased geriatric population, and raised awareness about eye diseases in developing countries are expected to boost the ophthalmic surgical devices and therapeutics market during the forecast period. Moreover, significant rise in incidence of eye-related diseases, especially in developed countries, is anticipated to drive the ophthalmic surgical devices and therapeutics market between 2018 and 2026. According to the Prevent Blindness Report, the number of people in the U.S. suffering from cataract is expected to increase from 24.4 million in 2010, to 30.5 million by 2020, and the number of people suffering from diabetic retinopathy in the U.S. is projected to rise from 7.7 million in 2010 to reach 9.2 million by 2020. 

ophthalmic surgical sevices therapeutics market

The global ophthalmic surgical devices and therapeutics market has been segmented based on product type, end-user, and region. In terms of product type, the global market has been classified into therapeutics, surgical devices, and vision care. The therapeutics segment dominates the ophthalmic surgical devices and therapeutics market, in terms of value. The therapeutics segment has been segmented further into anti-inflammatory drugs, anti-infective drugs, anti-glaucoma drugs, anti-allergy drugs, anti-VEGF agents, and others. The wide acceptance of therapeutics as the first line of treatment for any eye-related disorder is likely to drive the segment. The vision care segment is expected to expand at a significant CAGR during forecast period. This is primarily attributed to the increased prevalence of refractive errors among the population, including the young population. According to an article published by Journal of Current Ophthalmology, in 2018, astigmatism is a highly common refractive error among children and adults, followed by hyperopia and myopia. Myopia and astigmatism are highly prevalent among adults in Southeast Asia, and a considerably high prevalence of hyperopia is found among the children and adults in the U.S. population. 

In terms of end-user, the ophthalmic surgical devices and therapeutics market has been segregated into hospitals, ophthalmic clinics, and ambulatory surgery centers. The hospitals segment held a major share of the market in 2017, followed by ophthalmic clinics. The hospitals segment is expected to maintain its market share during the forecast period due to increased preferences for hospitals for any eye-related diseases. The ophthalmic clinics segment is projected to expand at a considerable CAGR during the forecast period. The high growth rate of this segment is due to its convenience, improved security, one-stop service offered by clinics, improved infrastructure, and increased preferences to ophthalmic clinics for IVT (Intravitreal) administration. 

In terms of region, the ophthalmic surgical devices and therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the ophthalmic surgical devices and therapeutics market, owing to the high awareness about eye-related disorders in the U.S., increased prevalence of eye diseases, technological advancements, and healthcare spending in the region. The market in Asia Pacific is anticipated expand at a considerably high CAGR during the forecast period, owing to the increased awareness regarding ocular diseases in developing countries, such as India, and governments’ initiatives for prevention of blindness in the region. 

Major players operating in the ophthalmic surgical devices and therapeutics market include Allergan Plc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Carl Zeiss Meditec AG, HOYA Corporation, and Bayer AG. Key players are expanding their product portfolios through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical companies, which is expected to increase product availability, and thereby boost the market.

Ophthalmic Surgical Devices and Therapeutics Market: Overview

This report analyzes the current and future scenario of the global ophthalmic surgical devices and therapeutics market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of ocular disorders, and high unmet medical needs are likely to be major drivers of the global ophthalmic surgical devices and therapeutics market during the forecast period. 

The ophthalmic surgical devices and therapeutics market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on product type, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the ophthalmic surgical devices and therapeutics market. 

Ophthalmic Surgical Devices and Therapeutics Market: Key Segments

Based on product type, the global ophthalmic surgical devices and therapeutics market has been segmented into therapeutics, surgical devices, and vision care. In terms of end-user, the global ophthalmic surgical devices and therapeutics market has been divided into hospitals, ophthalmic clinics, and ambulatory surgery centers. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. 

Ophthalmic Surgical Devices and Therapeutics Market: Regional Outlook

In terms of region, the global ophthalmic surgical devices and therapeutics market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in the Report

The report also profiles major players operating in the global ophthalmic surgical devices and therapeutics market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Carl Zeiss Meditec AG, HOYA Corporation, and Bayer AG. The global ophthalmic surgical devices and therapeutics market has been segmented as below:

  • Ophthalmic Surgical Devices and Therapeutics Market, by Product Type
    • Therapeutics
      • Anti-inflammatory Drugs
        • NSAIDs
        • Steroids
      • Anti-infective Drugs
        • Anti-fungal Drugs
        • Anti-bacterial Drugs
        • Others
      • Anti-infective Drugs
        • Alpha Agonist
        • Beta Blockers
        • Prostaglandin Analogs
        • Combined Medication
        • Others
      • Anti-allergy Drugs
      • Anti-VEGF Agents
      • Others
    • Surgical Devices
      • Cataract Surgery Devices
        • Intraocular lens (IOL)
        • Ophthalmic Viscoelastic Devices (OVDs)
        • Others
      • Glaucoma Surgery Devices
      • Refractive Surgery Devices
      • Vitreoretinal Surgery Devices
    • Vision Care
      • Contact Lenses
      • Spectacle Lenses
      • Accessories
  • Ophthalmic Surgical Devices and Therapeutics Market, by End-user
    • Hospitals
    • Ophthalmic Clinics
    • Ambulatory Surgery Centers
  • Ophthalmic Surgical Devices and Therapeutics Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • South Africa
      • GCC Countries
      • Rest of Middle East & Africa
.